Strategic Initiative
Slingshot members are tracking this corporate initiative:
BioLife Solutions (BLFS) Announces 10-Year Supply Agreement with TissueGene for CryoStor Use in Invossa Osteoarthritis Cell-Mediated Gene Therapy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLFS |
|
|
TissueGene |
|
|
|
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Dec 20, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2018
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Supply Agreement, 10 Year, Cryostor, Invossa, Osteoarthritis, Cell-mediated Gene Therapy
